Archives202520242023202220212020201920182017201620152014201320122011 March 13, 2025ImmuPharma proves unique Mechanism of Action of P140 Read More February 22, 2025TR1 from Lanstead – Major interest in shares Read More February 13, 2025Lanstead Subscription & Oversubscribed Placing to ‘c.£2.91 million | Sharing Agreement | Related Party Transactions Read More January 28, 2025Response to Share Price Movement Read More January 09, 2025ImmuPharma Announces Breakthrough Findings into Autoimmune Diseases Read More January 08, 2025Immupharma at JP MORGAN CONFERENCE and BIOTECH SHOWCASE 11-16 January 2025, San Francisco Read More December 24, 2024Change of Auditor Read More December 04, 2024Appointment of Company Secretary Read More October 11, 2024Notification of Major Holding – Lanstead Capital Read More September 11, 2024Extension of Warrants in Incanthera to 31 March 2025 Read More September 09, 2024INTERIM RESULTS for the six months ended 30 June 2024 Read More August 06, 2024TR1 – Major Holding – Lanstead Read More 1234…24
February 13, 2025Lanstead Subscription & Oversubscribed Placing to ‘c.£2.91 million | Sharing Agreement | Related Party Transactions Read More
January 08, 2025Immupharma at JP MORGAN CONFERENCE and BIOTECH SHOWCASE 11-16 January 2025, San Francisco Read More
